Cardiovascular Abnormalities Clinical Trials

A listing of Cardiovascular Abnormalities medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.



Lynn Institute of the Ozarks
Little Rock Arkansas 72205

Osteoarthritis or Rheumatoid Arthritis



Holy Cross Jim Moran Heart and Vascular Research Institute
Fort Lauderdale Florida 33308

ODYSSEY OUTCOME STUDY - A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome

University Clinical Research, Inc.
Pembroke Pines Florida 33024

Men and Women ages 18 or older with High Blood Pressure and Diabetes Type 2 who DO NOT require the use of Insulin to control their Diabetes Levels

Metabolic Research Institute, Inc.
West Palm Beach Florida 33401

Previous heart attack or stroke? Cardiovascular disease? Diabetes? Elevated blood sugar levels?


Via Christi Research
Wichita Kansas 67214

CardioVascular Health in Diabetes [THEMIS]


University of Kentucky Chandler Medical Center
Lexington Kentucky 40536

Cardiology & Vascular Diseases: Research Study on Weight Loss and Cardiovascular Disease



The Center for Rheumatology and Bone Research
Wheaton Maryland 20902

A randomized, double-blind study to compare the cardiovascular safety of allopurinol and febuxostat



Bay City Michigan 48708

A clinical research study of Mitroflow DL

Dearborn Michigan 48124

A clinical research study of Mitroflow DL

Detroit Michigan 48236

A clinical research study of Mitroflow DL

New York

Biomedical Research Alliance of New York
Bronx New York 10461

Acute Coronary Syndrome (ACS) subjects undergoing Ad Hoc percutaneous coronary intervention (PCI)




Optimum Clinical Research, Inc.
Salt Lake City Utah 84102

High Cholesterol and Cardiovascular Risk

Optimum Clinical Research, Inc.
Salt Lake City Utah 84102

Long-term outcomes study to assess statin residual risk reduction with Epanova (fish oil, omega-3 supplement) in high cardiovascular risk patients.


Charlottesville Virginia 22908

A clinical research study of Mitroflow DL